Cardiac Prosthetic Devices Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to cardiac prosthetic devices market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Cardiac Prosthetic Devices Market News

in Cardiac Prosthetic Devices Market
  • In February 2024, Edwards Lifesciences won FDA approval for its EVOQUE tricuspid valve replacement system, the first transcatheter treatment for tricuspid regurgitation in the U.S. The system employs a nitinol self-expanding frame and bovine pericardial tissue leaflets. It provides a minimally invasive alternative for high-risk patients, changing treatment for this underserved patient population.
  • In March 2024, Medtronic introduced the Avalus Ultra Valve, a bioprosthetic heart valve designed for durability and ease of use. The valve has improved tissue technology and a flexible stent, enhancing patient outcomes and surgical practice. It is a significant step forward in transcatheter heart valve replacement with long-term durability and great clinical performance.
  • In January 2025, Abbott launched the Navitor Vision transcatheter aortic valve implantation (TAVI) system in India. It carries radiopaque markers for better contrast, allowing enhanced accuracy in deploying the valve. The device works to deliver more efficient and safe treatment to stenotic aortic patients to ensure improved outcome and quicker healing.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiac Prosthetic Devices Market size was valued at USD 74.03 Billion in 2023 poised to grow from USD 77.53 Billion in 2024 to USD 112.21 Billion by 2032, growing at a CAGR of 4.73% in the forecast period (2025-2032).

The global cardiac prosthetic devices market competitive scenario is dominated by Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. These firms operate with innovation, mergers and acquisitions to keep the leadership intact. Edwards Lifesciences leads with research efforts in heart valve technologies, Medtronic continues to expand minimally invasive surgery solutions, and Abbott supplements its product portfolio with strategic acquisitions for a wide offering of advanced cardiac solutions. 'Edwards Lifesciences (USA)', 'Medtronic (Ireland)', 'Abbott Laboratories (USA)', 'Boston Scientific (USA)', 'CryoLife (USA)', 'Terumo Corporation (Japan)', 'Johnson & Johnson (USA)', 'Sorin Group (Italy)', 'LivaNova (UK)', 'Cardinal Health (USA)', 'Biotronik (Germany)', 'Tendyne (USA)', 'Aortic Medical (USA)', 'Mitsubishi Tanabe Pharma Corporation (Japan)', 'Vascular Solutions (USA)'

The rising incidences of cardiac diseases globally represent one of the biggest drivers in the global cardiac prosthetic devices market growth. As cardiac issues such as heart valve disease and coronary artery diseases rise, more prosthetic devices like heart valves and vascular grafts are required, which translates into greater opportunities for innovation and growth in the market.

Advancements in Minimally Invasive Procedures: The global cardiac prosthetic devices market trends are directing toward minimally invasive procedures, which reduce recovery times and risks. These kinds of devices, for example, transcatheter heart valves and catheter-based repair systems, are getting popular due to smaller incisions and faster recovery time.

What Factors Contribute to North America's Leadership in the Global Cardiac Prosthetic Devices Market?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Cardiac Prosthetic Devices Market
Cardiac Prosthetic Devices Market

Report ID: SQMIG35A3042

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE